| 2024-04-04 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0127% | $232.37 | $1.39M | +14.75% | |
| 2024-03-21 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0127% | $236.45 | $1.42M | +11.6% | |
| 2024-03-07 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0126% | $237.38 | $1.42M | +6.33% | |
| 2024-02-15 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0128% | $215.31 | $1.29M | +12.38% | |
| 2024-02-01 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0128% | $215.01 | $1.29M | +10.18% | |
| 2024-01-18 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0127% | $218.72 | $1.31M | +8.25% | |
| 2024-01-04 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0127% | $227.97 | $1.37M | +3.23% | |
| 2023-12-21 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0134% | $229.27 | $1.38M | +7.85% | |
| 2023-12-07 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0126% | $238.89 | $1.43M | -2.21% | |
| 2023-11-16 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0128% | $226.60 | $1.36M | +4.12% | |
| 2023-11-02 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0126% | $225.76 | $1.35M | +2.64% | |
| 2023-10-19 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0128% | $225.43 | $1.35M | +3.23% | |
| 2023-10-05 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0129% | $223.82 | $1.34M | +1.96% | |
| 2023-09-21 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0127% | $222.19 | $1.33M | +3.65% | |
| 2023-09-07 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0128% | $222.98 | $1.34M | +3.72% | |
| 2023-08-17 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0129% | $229.54 | $1.38M | +1.05% | |
| 2023-08-03 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 4,741 0.0103% | $237.12 | $1.12M | -0.48% | |
| 2023-08-03 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.013% | $236.25 | $1.42M | -0.48% | |
| 2023-07-20 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 2,500 0.0054% | $243.87 | $609,675 | -5.41% | |
| 2023-07-06 | Sale | United Therapeutics Corporation UTHR | EVP & GENERAL COUNSEL | 6,000 0.0131% | $215.19 | $1.29M | +8.51% |